Literature DB >> 31478562

Monetizing the MoCA: What Now?

Soo Borson1, Mandi Sehgal2, Joshua Chodosh3,4.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31478562     DOI: 10.1111/jgs.16158

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  4 in total

1.  Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.

Authors:  Nicholas M Pajewski; Dan R Berlowitz; Adam P Bress; Kathryn E Callahan; Alfred K Cheung; Larry J Fine; Sarah A Gaussoin; Karen C Johnson; Jordan King; Dalane W Kitzman; John B Kostis; Alan J Lerner; Cora E Lewis; Suzanne Oparil; Mahboob Rahman; David M Reboussin; Michael V Rocco; Joni K Snyder; Carolyn Still; Mark A Supiano; Virginia G Wadley; Paul K Whelton; Jackson T Wright; Jeff D Williamson
Journal:  J Am Geriatr Soc       Date:  2019-12-16       Impact factor: 5.562

2.  Telemedicine: A valuable tool in neurodegenerative diseases.

Authors:  Jamie L Adams; Taylor L Myers; Emma M Waddell; Kelsey L Spear; Ruth B Schneider
Journal:  Curr Geriatr Rep       Date:  2020-03-14

3.  Differentiating among stages of cognitive impairment in aging: Version 3 of the Uniform Data Set (UDS) neuropsychological test battery and MoCA index scores.

Authors:  Hiroko H Dodge; Felicia C Goldstein; Nicole I Wakim; Tamar Gefen; Merilee Teylan; Kwun C G Chan; Walter A Kukull; Lisa L Barnes; Bruno Giordani; Timothy M Hughes; Joel H Kramer; David A Loewenstein; Daniel C Marson; Dan M Mungas; Nora Mattek; Bonnie C Sachs; David P Salmon; Monica Willis-Parker; Kathleen A Welsh-Bohmer; Katherine V Wild; John C Morris; Sandra Weintraub
Journal:  Alzheimers Dement (N Y)       Date:  2020-11-24

4.  A novel hybrid scale for the assessment of cognitive and executive function: The Free-Cog.

Authors:  Alistair Burns; Judith R Harrison; Catherine Symonds; Julie Morris
Journal:  Int J Geriatr Psychiatry       Date:  2020-11-16       Impact factor: 3.850

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.